New Immunotherapy for Pet Cancer Study Results are Pawesome!
Immunotherapy for pet cancer in dogs and cats shows even more promise with new ELIAS study results released July 2022.
Immunotherapy for pet cancer in dogs and cats shows even more promise with new ELIAS study results released July 2022.
There’s new hope for dogs with advanced osteosarcoma lung metastasis, thanks to a new UC Davis Inhalation Chemotherapy Study for Dogs.
The Vaccine Against Canine Cancer Study is on, so learn how your dog might qualify with Dr. Jenna Burton, Director of UC Davis Vet Medicine Clinical Trials.
Clinical trials for pets can offer low-cost and affordable treatment, while helping to find better medical therapies for pets and people alike.
Osteosarcoma dogs enjoy long-term remission without chemotherapy thanks to ELIAS Cancer Immunotherapy Treatment and the University of Missouri Oncology Service.
Ready for the day we can prevent cancer with one inoculation? Scientists at three veterinary teaching hospitals are leading the way with the Vaccination Against Canine Cancer Study.
Exciting UC Davis dog cancer clinical trials for osteosarcoma and mast cell cancer announced at Morris Animal Foundation K9 Cancer Walk in Elk Grove, California.
Things to know about dog cancer clinical trials and how you can receive financial support, drug therapy, and treatments.
Cancer survivor Jerry participates in clinical study examining the effects of K9 Immunity immune boosting supplement.